Beyond Next-Token AI: NCM, Diffusion Models and the Startup Funding Race
Which startups can make AI generation faster without losing accuracy? An evidence-based look at NCM, Mercury 3, DiffuSpace Clover, Zyphra, funding rounds and commercial costs.
Explore our latest articles on ai-startups — covering venture capital deals, fund activity, startup fundraising strategy, and investor research relevant to this topic.
Whether you're a founder building an investor target list, an analyst tracking deal flow, or an operator researching market trends, the articles below provide practical, up-to-date venture capital intelligence.
Browse all ai-startups articles below, or use our investor list to research active investors by stage and sector.
Which startups can make AI generation faster without losing accuracy? An evidence-based look at NCM, Mercury 3, DiffuSpace Clover, Zyphra, funding rounds and commercial costs.
Compare AI drug-discovery startups and public companies by new financing, backers, pharma partnerships, software-vs-drug business model and clinical progress.
Ampersand raised a $15 million Bessemer-led Series A to connect enterprise AI agents with customized CRM, ERP and other systems of record.
Persona raised $10 million for an iMessage-based personal AI assistant and planned $179 wristband, but hardware delivery, trust and advertising conflicts remain unproven.
What Melius AI does, live creative-agent features, pricing and competitors, plus its $20M CRV-led Series A and $5M seed. Funding and product facts verified.
New York-based Faireez announced $7.5M in seed financing on March 6, 2025, to expand AI-supported housekeeping services for multifamily buildings.
New York startup Patlytics announced a $14M Series A on Feb. 24, 2025, to grow its AI-enabled patent analytics and workflow platform.
New York-based PromptLayer announced a $4.8M seed round on Feb. 7, 2025, as demand grows for tooling around LLM prompt workflows.
AI audio company ElevenLabs announced a $180M Series C on Jan. 30, 2025, at a reported $3.3B post-money valuation.